TraceLink, a leading digital network platform company enabling end-to-end product orchestration, has announced a partnership with PharmaLink.
TraceLink will provide comprehensive DSCSA capabilities for PharmaLink customers, enabling pharmacy dispensers to meet the regulatory requirements by connecting them with trading partners for faster, cheaper data compliance.
“After running a survey of the DSCSA vendor landscape on behalf of our pharmacy customers, it was clear that TraceLink was one of the only providers offering a comprehensive suite of solutions and supporting services for DSCSA dispenser compliance,” said Thierry Beckers, President and CEO of PharmaLink.
“Combined with PharmaLink’s web-based platform and services for reverse distribution, this strategic relationship will enable our customers to take advantage of TraceLink’s proven industry compliance leadership, as well as an integrated solution suite for DSCSA compliance; product verification; master data sharing; serialised product scanning; product recall intelligence and advanced drug shortage predictions. We are excited to recommend this shared capability exclusively to our customers.”
TraceLink has been investing for over a decade in deploying solutions to help pharmacies, hospitals and other members of the pharmaceutical supply chain meet serialisation, traceability, verification and other DSCSA requirements. In November 2023, the final phase of DSCSA goes into effect, bringing substantial new requirements on pharmacy dispensers to receive and manage serialised, or unit-level identified, medicines.